Provided by Tiger Trade Technology Pte. Ltd.

BOTANIX PHARMACEUTICALS LTD

0.055
0.000
Volume:4.12M
Turnover:224.50K
Market Cap:122.00M
PE:-1.19
High:0.055
Open:0.055
Low:0.054
Close:0.055
52wk High:0.485
52wk Low:0.052
Shares:2.22B
Float Shares:1.72B
Volume Ratio:1.07
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.046
EPS(LYR):-0.047
ROE:-121.11%
ROA:-53.38%
PB:2.26
PE(LYR):-1.17

Loading ...

Company Profile

Company Name:
BOTANIX PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
1984
Employees:
11
Office Location:
41-47 Colin Street,Suite 3,West Perth,Western Australia,Australia
Zip Code:
6005
Fax:
61 8 6210 1153
Introduction:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.